Clinical Trials Browser

Phase 2 × Ramucirumab × 30 days × Clear all

NCT03686488 2026-03-02

TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Phase 2 Completed

23 enrolled 12 charts

Gastrointestinal

Stomach Neoplasms

NCT06448754 2026-02-20

eVOLVE-01

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung